General
Nasdaq tower: An hour of eXoZymes
An hour of eXoZymes’ employees and messages as displayed on the Nasdaq tower in New York City on...
investors
CNBC closing bell footage from Feb 19, 2025
Part of the coverage of eXoZymes’ closing bell ceremony on Feb 19, 2025 from CNBC. Credit: CNBC...
investors
Nasdaq: eXoZymes CEO Michael Heltzen's closing bell speech
This Michael Heltzen's (CEO of eXoZymes) closing bell speech from February 19, 2025, when...
General
Nasdaq tower: enzymes x AI = exozymes
Captured on Feb 19, when the eXoZymes team rang the closing bell at Nasdaq in New York....
understanding exozymes
The difference between enzymes and exozymes: Explaining...
What is the difference between enzymes and exozymes? Listen to our CEO, Michael Heltzen, explain...
understanding exozymes
Vision: What's the potential impact of exozymes?
Listen to our CEO, Michael Heltzen, share his thoughts on how exozymes has the potential to be an...
investors
Looking at the rest of 2025 - part 4 of a fireside chat...
In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...
investors
Go To Market Strategy - part 3 of a fireside chat about...
In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...
investors
Using AI for Enzyme Engineering - part 2 of a fireside...
In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...
investors
Looking back at 2024 - part 1 of a fireside chat about...
In this video - recorded on Dec 29, 2024 - Lou Basenese interviews Michael Heltzen about going...
interview
Invizyne awarded $250K voucher from DoE
CEO of Invizyne, Michael Heltzen, states, “As a part of our journey from developing brand new...
investors
Invizyne IPO comments by CEO Michael Heltzen
Today's Nasdaq IPO marks new era of biomanufacturing - pioneered by Invizyne's breakthrough...